BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Yashwant Pathak, Deepak Thassu, Michel Deleers. Nanoparticulate Drug Delivery SystemsDrugs and the Pharmaceutical Sciences 2007; 20075578: 185 doi: 10.1201/9781420008449.ch13
W YU, D SU. Artificial Cells, Cell Engineering and Therapy2007; : 103 doi: 10.1533/9781845693077.1.103
Shiya Gao, Yurui Xu, Sajid Asghar, Minglei Chen, Lang Zou, Sulieman Eltayeb, Meirong Huo, Qineng Ping, Yanyu Xiao. Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systemsJournal of Drug Targeting 2015; 23(6): 481 doi: 10.3109/1061186X.2015.1020426
Youpeng Jia, Jun Ji, Feng Wang, Liangang Shi, Jingbo Yu, Dong Wang. Formulation, characterization, andin vitro/vivostudies of aclacinomycin A-loaded solid lipid nanoparticlesDrug Delivery 2014; : 1 doi: 10.3109/10717544.2014.974001
Harmeet Kaur, Jasbir Singh. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials2015; : 5858 doi: 10.1081/E-EBPP-120050041
Alina Shapira, Yoav D. Livney, Henk J. Broxterman, Yehuda G. Assaraf. Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistanceDrug Resistance Updates 2011; 14(3): 150 doi: 10.1016/j.drup.2011.01.003
Marina A. Dobrovolskaia, Scott E. McNeil. Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicinesJournal of Controlled Release 2013; 172(2): 456 doi: 10.1016/j.jconrel.2013.05.025
Kalyani C. Patil, Jatinder Vir Yakhmi. Nanobiomaterials in Cancer Therapy2016; : 395 doi: 10.1016/B978-0-323-42863-7.00013-X
Georgi Yordanov. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics2019; : 59 doi: 10.1016/B978-0-12-816963-6.00004-2